Company:  URIGEN PHARMACEUTICALS, I ...
Form Type:  8-K
Filing Date:  9/12/2012 
CIK:  0000932352 
Address:  501 SILVERSIDE ROAD PMB#95 
City, State, Zip:  WILMINGTON, Delaware 19809 
Telephone:  (925) 280-2861 
Fiscal Year:  06/30 
Description of Business
We specialize in the development of innovative products for patients with urological ailments including, specifically, the development of innovative products for amelioration of Bladder Pain Syndrome/Interstitial Cystitis ("BPS" or "BPS/IC"). Urology represents a specialty pharmaceutical market of, according to the American Urology Association (the "AUA"), approximately 10,000 physicians in the United States. Urologists treat a variety of ailments of the urinary tract including urinary tract infections, bladder cancer, overactive bladder, urgency and incontinence and interstitial cystitis, a subset of BPS. Many of these indications, we believe, represent significant, underserved therapeutic market opportunities. Over the next several years, we believe, a number of key demographic and technological factors should accelerate growth in the market for medical therapies to treat urological disorders, particularly in our product categories.
Register for a Free Trial and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement
    SIGNATURE